← Open Payments lookup

KIMBERLY SMITH: Open Payments

NPI 1407492531 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,221 in 121 payments from 15 companies in 2025. Trend: 2023 $1,348 · 2024 $1,746 · 2025 $2,221

Food & beverage: $2,221
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.31$432
ABBVIE INC.18$381
Alkermes, Inc.15$361
Teva Pharmaceuticals USA, Inc.14$221
Otsuka America Pharmaceutical, Inc.8$171
E.R. Squibb & Sons, L.L.C.10$169
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$166
Lundbeck LLC4$82
Vanda Pharmaceuticals Inc.2$56
Axsome Therapeutics, Inc.2$52

Products named: INGREZZA, VRAYLAR, ARISTADA, REXULTI, COBENFY, CAPLYTA, AUSTEDO XR, UZEDY.

Industry payments across CO — which companies pay providers there.